I've been following the gene-editing field for years, and CRISPR's precision still amazes me, but what really keeps me up at night is the gap between what we can do in the lab and what we're actually ready to handle ethically. We recently saw a trial where base editing corrected a sickle-cell mutation in human cells, yet the costs and long-term risks remain foggy. Should we push forward with germline editing now, given that the technology could eliminate hereditary diseases, or are we moving too fast without a global consensus on consequences? I lean toward cautious optimism, but the unknowns trouble me.